BRAF mutation, TERT promoter mutation, and HER2 amplification in sporadic or neurofibromatosis‐related neurofibromas and malignant peripheral nerve sheath tumors: do these molecules have a signature in malignant transformation?-Reference-Cited by-同舟云学术

BRAF mutation, TERT promoter mutation, and HER2 amplification in sporadic or neurofibromatosis‐related neurofibromas and malignant peripheral nerve sheath tumors: do these molecules have a signature in malignant transformation?

Published:2020-07-29 Issue:9 Volume:128 Page:515-522
ISSN:0903-4641
Container-title:APMIS
language:en
Short-container-title:APMIS

Author:

Coskun Sinem¹,Gamsizkan Mehmet¹,Yilmaz Ismail²,Yalcinkaya Ulviye³,Sungur Mehmet Ali⁴,Buyucek Seyma¹,Onal Binnur¹

Affiliation:

1. Department of Pathology and Cytology School of Medicine Duzce University Duzce Turkey

2. Department of Pathology School of Medicine Istanbul Sultan Abdulhamid Khan Training and Research Hospital Istanbul Turkey

3. Department of Pathology School of Medicine Uludag University Bursa Turkey

4. Department of Statistics School of Medicine Duzce University Duzce Turkey

Publisher

Wiley

Subject

Microbiology (medical),General Medicine,Immunology and Allergy,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apm.13063

Reference27 articles.

1. Malignant peripheral nerve sheath tumor: Molecular pathogenesis and current management considerations

2. TERT promoter mutations and BRAF mutations are rare in sporadic, and TERT promoter mutations are absent in NF1-related malignant peripheral nerve sheath tumors

3. Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors

4. Telomerase activity is a biomarker for high grade malignant peripheral nerve sheath tumors in neurofibromatosis type 1 individuals

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ERBB2 and ERBB3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors;Anticancer Research;2022-04-30

2. Establishment and genomic characterization of a sporadic malignant peripheral nerve sheath tumor cell line;Scientific Reports;2021-03-11